- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05134909
Customized Contact Lenses
November 23, 2021 updated by: Geunyoung Yoon, University of Houston
Custom Vision-Corrective Lens Study
The overall goal of this project is to improve the visual quality of individuals who have abnormal corneal conditions that alter the shape of their cornea (eg.
keratoconus).
Patients with an abnormal corneal shape have substantial lower and higher order aberrations (distortions in the eye).
This results in reduced visual acuity which cannot be corrected by regular sphero-cylindrical correction.
Compensating for these aberrations has been challenging due to difficulty measuring their wavefront aberrations accurately and, consequently, manufacturing the custom contact lenses with irregular optical profiles.
This project is designed to systematically overcome these obstacles with a customized scleral and/or soft contact lens capable of compensating for the lower and higher order aberrations of the eye.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Geunyoung Yoon, PhD
- Phone Number: 7137437860
- Email: gyoon2@central.uh.edu
Study Contact Backup
- Name: Ayeswarya Ravikumar, PhD
- Phone Number: 7137431637
- Email: aravikum@central.UH.EDU
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able to read and understand the informed consent document in English
- 18 to 75 years of age
- Received diagnosis of keratoconus by a clinician
- Willing and able to follow instructions
Exclusion Criteria:
- Has best corrected visual acuity of 20/20 or better in the keratoconic eye(s).
- Normal/typical subjects
- Is unable to handle, insert, remove or care for the study lenses.
- Has any active anterior segment disease, pathology, or surgery affecting vision, refraction, or the ability to wear a contact lens
- History of ocular pharmacological treatment
- History of ocular trauma or surgery causing abnormal corneal curvature or distorted vision History of contact lens intolerance
- Pregnant at the time of enrollment in the study (self-reported- It has been shown hormonal changes during pregnancy may affect corneal biomechanics negatively)
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers under the age of 18 because it has been shown the average age of the appearance of Keratoconus is the second decade of life ( 15-18 years of age)
- Prisoners
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study: Keratoconus
Customized contact lenses will be fitted to each study subject based on their own optical defects.
|
The customized lenses are designed to correct the eye's optical aberrations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual acuity
Time Frame: up to 2 months
|
Snellen "Tumbling E" method will be used to determine the smallest visible letter that a subject can see.
|
up to 2 months
|
Contrast sensitivity
Time Frame: up to 2 months
|
Light and dark sinusoidal stripes (Gabor gratings) will used to determine the smallest contrast that a subject can see.
|
up to 2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Geunyoung Yoon, PhD, University of Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2021
Primary Completion (Anticipated)
March 1, 2024
Study Completion (Anticipated)
December 1, 2024
Study Registration Dates
First Submitted
November 11, 2021
First Submitted That Met QC Criteria
November 23, 2021
First Posted (Actual)
November 26, 2021
Study Record Updates
Last Update Posted (Actual)
November 26, 2021
Last Update Submitted That Met QC Criteria
November 23, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003195
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Keratoconus
-
The Cleveland ClinicUniversity of MarylandEnrolling by invitationKeratoconus | Keratoconus, Unstable | Keratoconus, StableUnited States
-
Eye Hospital Pristina KosovoActive, not recruitingKeratoconus | Keratoconus of Right Eye | Keratoconus, Unstable, Right EyeKosovo
-
Tianjin Eye HospitalRecruitingScansys, Pentacam, Keratoconus, Subclinical KeratoconusChina
-
Tianjin Eye HospitalActive, not recruitingScansys, Pentacam, Corvis ST, Keratoconus, Subclinical KeratoconusChina
-
Heba Allah Nashaat MohamedAssiut UniversityRecruitingKeratoconus, CollagenEgypt
-
Kent Wellish MDNot yet recruitingKeratoconus, Unstable
-
Kasr El Aini HospitalUnknownProgressive KeratoconusEgypt
-
Centre Hospitalier Régional Metz-ThionvilleCompletedProgressive Keratoconus
-
Glaukos CorporationCompletedProgressive KeratoconusUnited States
-
Tianjin Eye HospitalCompletedKeratoconus, StableChina
Clinical Trials on Customized contact lens
-
University of RochesterBoston Sight; Ovitz CorporationCompletedKeratoconusUnited States
-
CIBA VISIONCompleted
-
Bausch & Lomb IncorporatedCompleted
-
Coopervision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
CIBA VISIONUniversity of WaterlooCompleted
-
Coopervision, Inc.CORECompleted
-
University of RochesterCompleted
-
Bausch & Lomb IncorporatedCompleted